Tags

Type your tag names separated by a space and hit enter

Diminished alpha2-plasmin inhibitor activity associated with the use of imatinib mesylate in patients with Philadelphia chromosome-positive haematologic cancer.
Thromb Haemost. 2009 Jun; 101(6):1170-1.TH

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Letter

Language

eng

PubMed ID

19492163

Citation

Matsue, Kosei, et al. "Diminished Alpha2-plasmin Inhibitor Activity Associated With the Use of Imatinib Mesylate in Patients With Philadelphia Chromosome-positive Haematologic Cancer." Thrombosis and Haemostasis, vol. 101, no. 6, 2009, pp. 1170-1.
Matsue K, Matsuo K, Fujiwara H, et al. Diminished alpha2-plasmin inhibitor activity associated with the use of imatinib mesylate in patients with Philadelphia chromosome-positive haematologic cancer. Thromb Haemost. 2009;101(6):1170-1.
Matsue, K., Matsuo, K., Fujiwara, H., Iwama, K., Hayama, B. Y., Kimura, S., Yamakura, M., & Takeuch, M. (2009). Diminished alpha2-plasmin inhibitor activity associated with the use of imatinib mesylate in patients with Philadelphia chromosome-positive haematologic cancer. Thrombosis and Haemostasis, 101(6), 1170-1.
Matsue K, et al. Diminished Alpha2-plasmin Inhibitor Activity Associated With the Use of Imatinib Mesylate in Patients With Philadelphia Chromosome-positive Haematologic Cancer. Thromb Haemost. 2009;101(6):1170-1. PubMed PMID: 19492163.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Diminished alpha2-plasmin inhibitor activity associated with the use of imatinib mesylate in patients with Philadelphia chromosome-positive haematologic cancer. AU - Matsue,Kosei, AU - Matsuo,Keitaro, AU - Fujiwara,Hideaki, AU - Iwama,Kan-Ichi, AU - Hayama,Brian Y, AU - Kimura,Shun-Ichi, AU - Yamakura,Masayuki, AU - Takeuch,Masami, PY - 2009/6/4/entrez PY - 2009/6/6/pubmed PY - 2010/9/21/medline SP - 1170 EP - 1 JF - Thrombosis and haemostasis JO - Thromb Haemost VL - 101 IS - 6 SN - 0340-6245 UR - https://www.unboundmedicine.com/medline/citation/19492163/Diminished_alpha2_plasmin_inhibitor_activity_associated_with_the_use_of_imatinib_mesylate_in_patients_with_Philadelphia_chromosome_positive_haematologic_cancer_ DB - PRIME DP - Unbound Medicine ER -